These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16361042)

  • 21. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
    Ainsworth MA; Nielsen OH
    Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
    [No Abstract]   [Full Text] [Related]  

  • 22. [Management of ascitis in patients with cirrhosis].
    Arfaoui D; Ajmi S
    Tunis Med; 2007 Feb; 85(2):91-5. PubMed ID: 17665651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis.
    Stirnimann G; Berg T; Spahr L; Zeuzem S; McPherson S; Lammert F; Storni F; Banz V; Babatz J; Vargas V; Geier A; Stallmach A; Engelmann C; Trepte C; Capel J; De Gottardi A
    Aliment Pharmacol Ther; 2017 Nov; 46(10):981-991. PubMed ID: 28940225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
    Wang SZ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and management of patients with refractory ascites.
    Senousy BE; Draganov PV
    World J Gastroenterol; 2009 Jan; 15(1):67-80. PubMed ID: 19115470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current management of refractory ascites in patients with cirrhosis.
    Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
    J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIPS versus paracentesis for the treatment of refractory ascites.
    Lau A; Bay C; Nadir A
    Hepatology; 2004 Dec; 40(6):1476; author reply 1476-7. PubMed ID: 15565609
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of patients with cirrhosis and ascites.
    Runyon BA
    Semin Liver Dis; 1997; 17(3):249-60. PubMed ID: 9308129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
    N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of ascites in patients with cirrhosis. What to do when diuretics fail.
    Porayko MK; Wiesner RH
    Postgrad Med; 1992 Dec; 92(8):155-8, 161-6. PubMed ID: 1454665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
    Garcia N; Sanyal AJ
    Postgrad Med; 2001 Feb; 109(2):91-6, 101-3. PubMed ID: 11272697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
    Garcia-Tsao G
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of ascites in cirrhosis.
    Bataller R; Arroyo V; Ginès P
    J Gastroenterol Hepatol; 1997 Nov; 12(11):723-33. PubMed ID: 9430037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ascites].
    Maier KP
    Praxis (Bern 1994); 2008 Jul; 97(14):772-8. PubMed ID: 18717459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of ascites in cirrhosis.
    Wong F
    J Gastroenterol Hepatol; 2012 Jan; 27(1):11-20. PubMed ID: 21916992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Paracentesis in the treatment of ascites in cirrhotic patients].
    Uriz Otano J; Sort P; Arroyo V
    Gastroenterol Hepatol; 1999; 22(7):356-63. PubMed ID: 10535210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.